Editorial: Digital biomarkers in testing the safety and efficacy of new drugs in mental health: A collaborative effort of patients, clinicians, researchers, and regulators

• Johanna Maria Catharina Blom,
• Cristina Benatti,
• Deborah Mascalzoni,
• Deborah Mascalzoni,
• Fabio Tascedda,
• Luca Pani,
• Luca Pani,
• Luca Pani

Affiliations

Johanna Maria Catharina Blom

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

Cristina Benatti

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

Deborah Mascalzoni

Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden

Deborah Mascalzoni

Institute for Biomedicine, EURAC Research, Bolzano, Italy

Fabio Tascedda

Department of Life Science, University of Modena and Reggio Emilia, Modena, Italy

Luca Pani

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

Luca Pani

Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, United States

Luca Pani

Relmada Therapeutics, Coral Gables, FL, United States